PAR6 MODELING THE IMPACT OF PATIENT AND CLINICAL...

PAR6 MODELING THE IMPACT OF PATIENT AND CLINICAL HETEROGENEITIES ON THE COST-EFFECTIVENESS OF SELECTIVE COX-2 INHIBITORS SUCH AS LUMIRACOXIB AND CONVENTIONAL NSAIDS IN PATIENTS WITH OSTEOARTHRITIS

J Huels, A Wright, K Kahler, M Omar, RW Dubois, CF Chiou, OV Doan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Year:
2006
Language:
english
DOI:
10.1016/s1098-3015(10)64387-2
File:
PDF, 79 KB
english, 2006
Conversion to is in progress
Conversion to is failed